Pursuant to Regulation 57 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Ind-swift Laboratories has informed that the Company has made the payment of monthly interest for the month of June, 2019 to the Investors of Non-Convertible Debentures (NCDs), ISIN-INE915B07024, on 29th June, 2019.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| PropShare Celestia | 1025000.00 |
| ICICINXT50 | 75.42 |
| Citius Transnet Inve | 105.01 |
| EMAMILTD7 | 423.00 |
| Arihant Mangal Scheme | |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: